Bispectral Index (BIS) Versus Electronic Alerts in the Prevention of Anesthesia Awareness: the Michigan Awareness Control Study
NCT ID: NCT00689091
Last Updated: 2017-12-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22185 participants
INTERVENTIONAL
2008-05-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Every 5 minutes the alerting system checks every active case in our operating rooms. It takes approximately 1 second for this scan of all active cases to occur.
* Conditions for an "active case" are:
1. data capture is possible (i.e., not a paper record)
2. data capture is active (i.e., "patient in room" has been electronically entered and end-tidal \[Et\] CO2 is detected)
3. case has been identified as a general anesthetic
4. "anesthesia induction end" has already been documented
5. request for recovery room bed or transport to an intensive care unit has not been documented
6. surgical dressing completion has not been documented
* The alerting system checks the most recent value (within a specified time period) of:
1. Et Sevoflurane (MAC=2.0)
2. Et Isoflurane (MAC=1.2)
3. Et Desflurane (MAC=6)
4. Et Nitrous Oxide (MAC=105) and compares it to the MAC of each agent. It adds the resulting MAC values together for "current total MAC."
* The system then checks for a charted propofol infusion in mcg/kg/min and divides by 150, assuming that 150 mcg/kg/min is "1.0 MAC" for propofol. The analogous concept of MAC for propofol is "Cp50"- the plasma or blood concentrations at which 50% of patients do not move in response to a noxious stimulus. Since the investigators do not have the technology at our institution to calculate Cp50 or Cp50-awake, the investigators have chosen the above propofol dose as an initial value based on clinical experience. The resultant MAC equivalent is added to current total MAC.
* The system next checks for a dexmedetomidine infusion with a rate of 0.2 mcg/kg/hour or greater. If present, it multiplies the current total inhalational MAC by 2, as dexmedetomidine can reduce MAC by 50%.
* At this point, the "current total MAC" is defined as: Et Sevo /2 + Et Iso /1.2 + Et Des/6 + Et Nitrous /105 + propofol rate (in mcg/kg/min)/150. If dexmedetomidine is \>0.2 mcg/kg/hour, inhalational MAC is multiplied by 2.
* If this total mac \< 0.50, it checks to see if a bolus of propofol, midazolam, etomidate, or thiopental has been given in the preceding 10 minutes.
* It alerts the clinician signed into the case within 30-60 seconds if total age-adjusted MAC \< 0.50 AND no bolus has been documented in the last 10 minutes.
This will be the protocol in the MAC-guided group. In the BIS-guided group an electronic alert will be sent if the BIS value is \>60. If an alert is triggered, the clinician electronically signed into the case receives an alphanumeric page stating "Potentially insufficient anesthesia, please check vaporizers and intravenous lines."
The investigators are collaborating with Washington University, the University of Chicago, and the University of Mannitoba, who will also be testing a MAC-based protocol in comparison to the BIS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BIS group
This group will have BIS values visible and will receive alerts when the value is \>60.
Bispectral Index Monitor
Comparison of two different alerting protocols. One using the bispectral index monitor and one using the MAC alerting protocols.
MAC Alert
This group will receive an alert if total MAC (including intravenous infusions) is \<0.5 age-adjusted.
Electronic MAC alert
Comparison of two different alerting protocols. One using the bispectral index monitor and one using the MAC alerting protocols.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bispectral Index Monitor
Comparison of two different alerting protocols. One using the bispectral index monitor and one using the MAC alerting protocols.
Electronic MAC alert
Comparison of two different alerting protocols. One using the bispectral index monitor and one using the MAC alerting protocols.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foundation for Anesthesia Education and Research
OTHER
American Society of Anesthesiologists
OTHER
Washington University School of Medicine
OTHER
University of Chicago
OTHER
University of Manitoba
OTHER
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
George Mashour
Assistant Professor of Anesthesiology and Neurosurgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
George A. Mashour, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan Medical School, University Hospital
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vance JL, Shanks AM, Woodrum DT. Intraoperative bispectral index monitoring and time to extubation after cardiac surgery: secondary analysis of a randomized controlled trial. BMC Anesthesiol. 2014 Sep 18;14:79. doi: 10.1186/1471-2253-14-79. eCollection 2014.
Shanks AM, Avidan MS, Kheterpal S, Tremper KK, Vandervest JC, Cavanaugh JM, Mashour GA. Alerting thresholds for the prevention of intraoperative awareness with explicit recall: a secondary analysis of the Michigan Awareness Control Study. Eur J Anaesthesiol. 2015 May;32(5):346-53. doi: 10.1097/EJA.0000000000000123.
Avidan MS, Palanca BJ, Glick D, Jacobsohn E, Villafranca A, O'Connor M, Mashour GA; BAG-RECALL Study Group. Protocol for the BAG-RECALL clinical trial: a prospective, multi-center, randomized, controlled trial to determine whether a bispectral index-guided protocol is superior to an anesthesia gas-guided protocol in reducing intraoperative awareness with explicit recall in high risk surgical patients. BMC Anesthesiol. 2009 Nov 30;9:8. doi: 10.1186/1471-2253-9-8.
Mashour GA, Tremper KK, Avidan MS. Protocol for the "Michigan Awareness Control Study": A prospective, randomized, controlled trial comparing electronic alerts based on bispectral index monitoring or minimum alveolar concentration for the prevention of intraoperative awareness. BMC Anesthesiol. 2009 Nov 5;9:7. doi: 10.1186/1471-2253-9-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00013626
Identifier Type: -
Identifier Source: org_study_id